Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert E Gallagher

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Leukemia Research|July 1, 2008
SCANning for PML nuclear bodies with Myeloid Zinc Finger 1Robert E Gallagher
Leukemia Research|April 7, 2009
Real-time consensus on relapse risk in acute promyelocytic leukemiaRobert E Gallagher
Blood|August 13, 2011
Mutants strike again in APLRobert E Gallagher
Blood|February 7, 2002
Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivoDa-Cheng Zhou, Soon H Kim, Wei Ding, et al.
Cancer Research|August 2, 2014
Dynamics of leukemia stem-like cell extinction in acute promyelocytic leukemiaBenjamin Werner, Robert E Gallagher, Elisabeth M Paietta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemiaSteven D Gore, Ivana Gojo, Mikkael A Sekeres, et al.
Blood|December 7, 2002
Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129Robert E Gallagher, Beow Y Yeap, Wanli Bi, et al.
Haematologica|July 28, 2006
A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemiaMark R Litzow, Sandra Lee, John M Bennett, et al.
The American Journal of Pathology|July 24, 2012
KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivationXiaoMei Liu, Alejandro Gomez-Pinillos, Charisse Loder, et al.
Leukemia & Lymphoma|December 29, 2004
Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993)Janice P Dutcher, Sandra Lee, Robert E Gallagher, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Leukemia Research|July 1, 2008
SCANning for PML nuclear bodies with Myeloid Zinc Finger 1Robert E Gallagher
Leukemia Research|April 7, 2009
Real-time consensus on relapse risk in acute promyelocytic leukemiaRobert E Gallagher
Blood|August 13, 2011
Mutants strike again in APLRobert E Gallagher
Blood|February 7, 2002
Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivoDa-Cheng Zhou, Soon H Kim, Wei Ding, et al.
Cancer Research|August 2, 2014
Dynamics of leukemia stem-like cell extinction in acute promyelocytic leukemiaBenjamin Werner, Robert E Gallagher, Elisabeth M Paietta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemiaSteven D Gore, Ivana Gojo, Mikkael A Sekeres, et al.
Blood|December 7, 2002
Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129Robert E Gallagher, Beow Y Yeap, Wanli Bi, et al.
Haematologica|July 28, 2006
A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemiaMark R Litzow, Sandra Lee, John M Bennett, et al.
The American Journal of Pathology|July 24, 2012
KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivationXiaoMei Liu, Alejandro Gomez-Pinillos, Charisse Loder, et al.
Leukemia & Lymphoma|December 29, 2004
Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993)Janice P Dutcher, Sandra Lee, Robert E Gallagher, et al.
Pageof 2